✦ LIBER ✦

Once-a-day extended-release versus two-times-daily immediate-release methylphenidate for the treatment of adhd - A cost minimization study

✍ Scribed by Kachru, N.; Sansgiry, S.S.

Book ID: 122279176
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 71 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.1586

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative efficacy of once–a–day exten

Comparative efficacy of once–a–day extended–release methylphenidate, two–times–daily immediate–release methylphenidate, and placebo in a laboratory school setting

✍ M. Döpfner; W. D. Gerber; T. Banaschewski; D. Breuer; F. J. Freisleder; G. Gerbe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 357 KB

(813): Oral once-a-day AVINZA (morphine

(813): Oral once-a-day AVINZA (morphine sulfate extended-release capsules) vs. twice daily OxyContin (oxycodone hydrochloride controlled-release): A randomized, multicenter study for the treatment of chronic moderate to severe low back pain

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; A. Negro-Vilar; E. De Jong; S. G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

Randomized, multi-center study of oral o

Randomized, multi-center study of oral once-a-day AVINZA® (morphine sulfate extended-release capsules) vs. twice daily OxyContin® (oxycodone hydrochloride controlled-release) for the treatment of chronic moderate to severe low back pain

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; E. de Jong; S. Gershon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

(765): Long-term improvement in physical

(765): Long-term improvement in physical function observed in the ACTION Trial: A randomized, multi-center study of once daily AVINZA® (morphine sulfate extended-release capsules) versus twice daily OxyContin® (oxycodone hydrochloride controlled-release) for modera

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; S. Gershon; R. Ghalie; E. De Jon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 35 KB

(827): Oral once-a-day AVINZA (morphine

(827): Oral once-a-day AVINZA (morphine sulfate extended-release capsules) vs. twice daily OxyContin (oxycodone hydrochloride controlled-release) for the treatment of chronic moderate-to-severe low back pain; final (part I and part II) study results

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; A. Negro-Vilar; E. De Jong; S. G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB